Efficacy and immune activation of ipilimumab in early-stage lung cancer patients.
about
Efficacy and immune activation of ipilimumab in early-stage lung cancer patients.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Efficacy and immune activation of ipilimumab in early-stage lung cancer patients.
@en
Efficacy and immune activation of ipilimumab in early-stage lung cancer patients.
@nl
type
label
Efficacy and immune activation of ipilimumab in early-stage lung cancer patients.
@en
Efficacy and immune activation of ipilimumab in early-stage lung cancer patients.
@nl
prefLabel
Efficacy and immune activation of ipilimumab in early-stage lung cancer patients.
@en
Efficacy and immune activation of ipilimumab in early-stage lung cancer patients.
@nl
P2860
P356
P1476
Efficacy and immune activation of ipilimumab in early-stage lung cancer patients
@en
P2093
Kazuhiro Yatera
Shingo Noguchi
P2860
P304
S1945-S1948
P356
10.21037/JTD.2018.05.108
P433
P577
2018-06-01T00:00:00Z